Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 19,765 full-time employees. The company went IPO on 2005-09-28. The firm is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The firm is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.
Qui est le CEO de Daiichi Sankyo Company, Limited ?
Mr. Sunao Manabe est le Chairman of the Board de Daiichi Sankyo Company, Limited, il a rejoint l'entreprise depuis 2012.
Quelle est la performance du prix de l'action Daiichi Sankyo Co., Ltd. ?
Le prix actuel de Daiichi Sankyo Co., Ltd. est de $19.03, il a augmenté de 0.31% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Daiichi Sankyo Company, Limited ?
Daiichi Sankyo Company, Limited appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quel est la capitalisation boursière de Daiichi Sankyo Company, Limited ?
La capitalisation boursière actuelle de Daiichi Sankyo Company, Limited est de $35.1B
Est-ce que Daiichi Sankyo Company, Limited est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 19 analystes ont établi des notations d'analystes pour Daiichi Sankyo Company, Limited, y compris 8 achat fort, 12 achat, 1 maintien, 0 vente et 8 vente forte